Harmony Biosciences Management, Inc.
Clinical trials sponsored by Harmony Biosciences Management, Inc., explained in plain language.
-
New hope for Prader-Willi syndrome: drug targets extreme daytime sleepiness
Symptom relief Recruiting nowThis study tests a medication called pitolisant to see if it can reduce excessive daytime sleepiness in people aged 6 and older with Prader-Willi syndrome. About 134 participants will receive either the drug or a placebo, and researchers will also check if it helps with irritabil…
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated May 26, 2026 11:14 UTC
-
New hope for chronic sleepiness: experimental drug enters final testing phase
Symptom relief Recruiting nowThis study tests an experimental drug called HBS-301 in 248 adults with idiopathic hypersomnia, a condition causing severe daytime sleepiness, trouble waking up, and fatigue. Participants will receive either the drug or a placebo for several weeks to see if it reduces symptoms. T…
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC